Community-Acquired Pneumonia: Defining the problem

Infections in Medicine

Volumn 15, Issue 8 SUPPL. E, 1998, Pages 11-19

  Niederman, Michael S ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Antibiotics; Community acquired pneumonia (CAP); Lower respiratory tract infection (LRTI); Switch therapy

Indexed keywords

EID: 0001862037     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Marston BJ, Plouffe JF, File TM Jr, et al: Incidence of community-acquired pneumonia requiring hospitalization: Results of a population-based surveillance study in Ohio: The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 157:1709-1718, 1997.
2. Fine MJ, Smith MA, Carson CA, et al: Prognosis and outcomes of patients with community-acquired pneumonia: A meta-analysis. JAMA 275:134-141, 1996.
3. Fine MJ, Auble TE, Yealy DM, et al: A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243-250, 1997.
4. Fine MJ, Hough LJ, Medsger AR, et al: The hospital admission decision for patients with community-acquired pneumonia: Results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 157:36-44, 1997.
5. Lieberman D, Schlaeffer F, Boldur I, et al: Multiple pathogens in adult patients admitted with community-acquired pneumonia: A one-year prospective study of 346 consecutive patients. Thorax 51:179-184, 1996.
6. Marrie TJ, Peeling RW, Fine MJ, et al: Ambulatory patients with community-acquired pneumonia: The frequency of atypical agents and clinical course. Am J Med 101:508-515, 1996.
7. Kauppinen MT, Saikku P, Kujala P, et al: Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: A comparison between chlamydial and pnemococcal pneumonia. Thorax 51:185-189, 1996.
8. Pallares R, Lilnares J, Vadillo M, et al: Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 333:474-480, 1995.
9. Plouffe JF, Breiman RF, Facklam RR: Bacteremia with Streptococcus pneumoniae: Implications for therapy and prevention: Franklin County Pneumonia Study Group. JAMA 275:194-198, 1996.
10. Clavo-Sanchez AJ, Giron-Gonzalez JA, Lopez-Prieto D: Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus penumoniae: A multicenter study. Clin Infect Dis 24:1052-1059, 1997.
11. Ramirez JA: Switch therapy in adult patients with pneumonia. Clin Pulm Med 2:327, 1995.
12. Siegel RE, Halpern NA, Almenoff PL, et al: A prospective randomized study of inpatient IV antibiotics for community-acquired pneumonia: The optimal duration of therapy. Chest 110:965-971, 1996.
13. Chan R, Hemeryck L, O'Regan M: Oral versus intravenous antibiotics for community-acquired lower respiratory tract infection in a general hospital: Open, randomised controlled trial. BMJ 310:1360-1362, 1995.
14. Degelau J, Guay D, Straub K, et al: Effectiveness of oral antibiotic treatment in nursing home-acquired pneumonia. J Am Geriatr Soc 43:245-251, 1995.
15. Coley CM, Li YH, Medsger AR, et al: Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia. Arch Intern Med 156:1565-1571, 1996.
16. Gleason PP, Kapoor VVN, Stone RA, et al: Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia. JAMA 278:32-39, 1997.
17. Gantz N: Patient compliance in the management of adult respiratory infections. Internal Medicine for the Specialist 10:1-3, 1990.
18. Gallup Organization: Consumer Attitudes Toward Antibiotic Use. American Lung Association, New York, 1995.